4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0002076327-26-000002
Options or other derivatives
- Chief Scientific Officer acquired 430,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kolbeck Roland Wilhelm · Chief Scientific Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-02 | Grant or award : show line 1 in the form Restricted Stock Units | +95,700 | 95,700 | D |
| 2026-02-02 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +334,900 | 334,900 | D |
Loading xslF345X05/form4-02062026_110219.xml…